Latest Ratios: P/E Ratio -2.2x · EV/EBITDA N/A · ROE -80.9%. (1996–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $310M | $265M | $213M | $190M | $214M | $257M | $215M | $255M | $281M | $283M | $223M |
| Enterprise Value | $357M | $312M | $302M | $317M | $324M | $382M | $362M | $398M | $431M | $465M | $417M |
| P/E Ratio → | -2.17 | — | 30.74 | 104.00 | 17.12 | 7.38 | 9.06 | 6.74 | 21.53 | — | 31.98 |
| P/S Ratio | 7.04 | 6.01 | 4.57 | 4.76 | 2.32 | 2.37 | 2.32 | 2.09 | 3.45 | 2.18 | 1.55 |
| P/B Ratio | 2.96 | 2.45 | 0.83 | 0.76 | 0.86 | 1.03 | 0.97 | 1.28 | 1.58 | 1.71 | 1.25 |
| P/FCF | 21.20 | 18.11 | — | — | — | — | — | 8.87 | 123.49 | 19.05 | 13.91 |
| P/OCF | 15.40 | 13.16 | — | — | 32.76 | 15.60 | 204.51 | 5.22 | 14.72 | 10.04 | 7.35 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 7.08 | 6.48 | 7.97 | 3.52 | 3.52 | 3.92 | 3.26 | 5.30 | 3.58 | 2.89 |
| EV / EBITDA | — | — | — | 28.11 | — | 12.92 | 17.09 | 6.77 | 17.73 | 50.89 | 11.21 |
| EV / EBIT | — | — | 20.85 | 43.06 | 19.89 | 7.58 | 9.70 | 6.94 | 19.84 | — | 19.11 |
| EV / FCF | — | 21.35 | — | — | — | — | — | 13.87 | 189.61 | 31.24 | 26.01 |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | -436.2% | -436.2% | -120.9% | 16.2% | -16.1% | 22.0% | 19.4% | 49.4% | 31.5% | 6.9% | 24.3% |
| Operating Margin | -462.7% | -462.7% | -144.6% | -10.5% | -27.0% | 13.3% | 7.5% | 37.0% | 13.0% | -4.7% | 15.2% |
| Net Profit Margin | -334.3% | -334.3% | 14.9% | 4.6% | 13.6% | 32.1% | 25.6% | 30.9% | 16.1% | -7.3% | 4.8% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -80.9% | -80.9% | 2.8% | 0.7% | 5.0% | 14.8% | 11.2% | 20.1% | 7.6% | -5.5% | 4.0% |
| ROA | -49.1% | -49.1% | 1.7% | 0.4% | 3.0% | 8.1% | 5.6% | 9.0% | 3.1% | -2.2% | 1.5% |
| ROIC | -61.1% | -61.1% | -14.0% | -0.9% | -5.1% | 2.9% | 1.5% | 10.1% | 2.3% | -1.3% | 4.4% |
| ROCE | -69.8% | -69.8% | -16.8% | -1.0% | -6.2% | 3.5% | 1.7% | 11.4% | 2.6% | -1.5% | 5.0% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.79 | 0.79 | 0.36 | 0.51 | 0.45 | 0.50 | 0.68 | 0.81 | 0.99 | 1.12 | 1.13 |
| Debt / EBITDA | — | — | — | 11.40 | — | 4.24 | 7.12 | 2.76 | 7.22 | 20.23 | 5.39 |
| Net Debt / Equity | — | 0.44 | 0.35 | 0.51 | 0.44 | 0.50 | 0.67 | 0.72 | 0.85 | 1.10 | 1.09 |
| Net Debt / EBITDA | — | — | — | 11.31 | — | 4.21 | 6.97 | 2.44 | 6.18 | 19.85 | 5.22 |
| Debt / FCF | — | 3.24 | — | — | — | — | — | 4.99 | 66.11 | 12.19 | 12.10 |
| Interest Coverage | -37.35 | -37.35 | 4.10 | 1.50 | 4.90 | 12.63 | 6.25 | 8.00 | 2.54 | -0.44 | 2.21 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.56 | 9.56 | 3.81 | 3.90 | 1.91 | 2.46 | 2.45 | 2.14 | 3.31 | 4.16 | 3.85 |
| Quick Ratio | 8.83 | 8.83 | 0.99 | 0.42 | 0.24 | 0.52 | 0.52 | 0.75 | 1.40 | 1.89 | 0.72 |
| Cash Ratio | 6.64 | 6.64 | 0.30 | 0.07 | 0.05 | 0.04 | 0.15 | 0.64 | 1.18 | 0.21 | 0.35 |
| Asset Turnover | — | 0.22 | 0.12 | 0.09 | 0.22 | 0.25 | 0.22 | 0.29 | 0.19 | 0.31 | 0.32 |
| Inventory Turnover | 55.99 | 55.99 | 3.42 | 0.64 | 3.85 | 1.95 | 1.83 | 1.54 | 1.36 | 3.34 | 1.87 |
| Days Sales Outstanding | — | 11.20 | 21.36 | 17.51 | 5.72 | 31.39 | 20.23 | 2.13 | 11.42 | 12.05 | 14.56 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 0.5% | 0.6% | 0.7% | 2.6% | 7.1% | 2.8% | 1.1% | 0.7% | 0.7% | 0.7% | 0.9% |
| Payout Ratio | — | — | 21.9% | 268.8% | 121.2% | 20.5% | 10.4% | 4.8% | 15.1% | — | 28.5% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | 3.3% | 1.0% | 5.8% | 13.6% | 11.0% | 14.8% | 4.6% | — | 3.1% |
| FCF Yield | 4.7% | 5.5% | — | — | — | — | — | 11.3% | 0.8% | 5.2% | 7.2% |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.1% | 10.0% | 0.8% | 1.1% | 1.4% |
| Total Shareholder Yield | 0.5% | 0.6% | 0.7% | 2.6% | 7.1% | 2.8% | 1.3% | 10.8% | 1.5% | 1.8% | 2.3% |
| Shares Outstanding | — | $8M | $8M | $8M | $8M | $8M | $7M | $7M | $8M | $8M | $8M |
Operational viability of citrus
As reported in recent financial filings, Alico's negative TTM P/E of -2.14 and lack of meaningful EV/EBITDA multiples suggest that the market is currently valuing the company as a land-holding entity rather than a traditional operating business, effectively ignoring the distressed earnings power of its citrus segment.
The current P/S ratio of 6.95 appears elevated relative to the company's inability to generate consistent revenue, implying that investors are pricing in the liquidation value of the 83,000-acre land bank. This valuation approach warrants caution, as it assumes the land can be monetized at book value despite the ongoing operational decay in the citrus groves.
Based on the company's reported figures, ROIC has remained consistently negative, reaching a low of -41.2% in 2025Q2, which indicates that the capital deployed into grove maintenance and replanting efforts is failing to generate a return that covers the cost of the underlying biological assets.
The persistent negative ROIC suggests that the company is effectively destroying shareholder value through its current operational model. Investors should monitor whether the recent modernization efforts can reverse this trend, or if the structural impact of citrus greening has permanently impaired the company's ability to compound capital.
According to quarterly data, Alico's asset turnover has remained extremely low at approximately 0.03, reflecting a structural inability to generate revenue from its massive land base, while the cash conversion cycle has shown extreme volatility, peaking at 481 days in 2024Q4 due to harvest timing.
The erratic nature of the cash conversion cycle highlights the company's vulnerability to seasonal harvest cycles and the lack of control over production timelines. This inefficiency suggests that the company's working capital management is secondary to the broader, more pressing challenge of maintaining tree health and yield.
As indicated by the company's financial statements, the current ratio of 9.63 in 2026Q2 provides a significant liquidity cushion, yet this metric may be misleading given that a large portion of current assets is tied to biological inventory that is subject to significant impairment risk.
While the high current ratio suggests a strong ability to meet short-term obligations, the underlying quality of these assets remains questionable due to the ongoing citrus greening crisis. The company's liquidity position appears robust on paper, but it may be rapidly depleted if the current rate of operational cash burn continues.
Investors frequently misapply the P/B ratio to Alico, as reported in various market analyses, because it fails to account for the significant, non-cash impairments of biological assets that have historically distorted the company's book value and masked the true economic reality of the citrus business.
Using P/B as a primary valuation metric obscures the fact that the book value of the groves may not reflect their current productive capacity or market value in a post-greening environment. A more appropriate metric would be a risk-adjusted Net Asset Value (NAV) that explicitly discounts the land based on its potential for non-agricultural development.
Includes 30+ ratios · 30 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying ALCO stock.
Alico, Inc.'s current P/E ratio is -2.2x. The historical average is 28.6x.
Alico, Inc.'s return on equity (ROE) is -80.9%. The historical average is 4.0%.
Based on historical data, Alico, Inc. is trading at a P/E of -2.2x. Compare with industry peers and growth rates for a complete picture.
Alico, Inc.'s current dividend yield is 0.48%.
Alico, Inc. has -436.2% gross margin and -462.7% operating margin.